Nasal Circulating DNA (ncDNA) as a Biomarker for Lung Cancer Detection and Advanced Disease Monitoring

• Forschungsstelle: INNOSUISSE
• Projektnummer: 125.789 IP-LS
• Projekttitel Englisch: Nasal Circulating DNA (ncDNA) as a Biomarker for Lung Cancer Detection and Advanced Disease Monitoring

Schlüsselwörter (Englisch)

Life sciences, Medical diagnostics

Abstract (Englisch)

This proposal validates nasal circulating DNA (ncDNA) as a non-invasive tool for advanced lung cancer monitoring. The technology aims to enhance targeted therapy selection, disease monitoring, and provide a complementary alternative to blood-based liquid biopsies